Hypoxia is known to modulate central host cell signaling pathways involved in metabolism and ϳϵ survival and it regulates the expression of multidrug resistance transporters via the hypoxia-ϴϬ inducible factor-1α (HIF-1α) (29). We and others showed that chlamydiae well adapted to a low ϴϭ oxygen environment and directly interfered with the stabilization of HIF-1α, the central ϴϮ mammalian oxygen sensor, to replicate (17, 26) . In addition, IFN-γ could not control intracellular Thus, doxycycline (2 µg/mL) and azithromycin (0.5 µg/mL) treatment were significantly less ϭϳϯ effective against early intracellular chlamydial growth when the cells were grown in hypoxia ϭϳϰ ( Fig. 2 and 3 ). When the doxycycline concentration was reduced (0.5 µg/mL) significantly less ϭϳϱ chlamydiae were killed in hypoxia compared to normoxia whereas an increase to 8 µg/mL ϭϳϲ resulted in complete eradication of chlamydiae under both conditions (Fig. 2B ). The same trend ϭϳϳ was observed for azithromycin ( Fig. 3B ). In contrast, both moxifloxacin and rifampin were ϭϳϴ equally efficient in eradicating intracellular C. trachomatis at concentrations of 3 µg/mL and 8 ϭϳϵ µg/mL, respectively (data not shown). However, when the concentrations of moxifloxacin and ϭϴϬ rifampin were reduced to 0.5 µg/mL C. trachomatis was significantly more effectively ϭϴϭ eradicated in normoxia than in hypoxia ( significantly different between normoxic and hypoxic conditions (n=7) (A). Immunofluorescence stainings showed reduced efficacy of DOX (2 µg/mL) against C. trachomatis under hypoxic conditions (B). Significant differences in the antichlamydial activity of doxycycline between normoxia and hypoxia were also observed when the concentration of the antimicrobial was reduced (0.5 µg/mL) but not when the concentration was increased (8 µg/mL) (C). Recoverable chlamydiae at indicated time points were calculated as the percentage of the untreated control under normoxia and hypoxia, respectively. (n=4; mean ± SEM, *p<0.05. Nox: normoxia, Hox: hypoxia). showed reduced efficacy of AZM (0.5 µg/mL) against C. trachomatis under hypoxic conditions (A). Differences in the efficacy of AZM in early intracellular C. trachomatis eradication with respect to the oxygen availability were maintained when the concentration was decreased to 0.04 µg/mL and even more pronounced when the concentration was enhanced to 0.5 µg/mL (B). Recoverable chlamydiae at indicated time points were calculated as the percentage of the untreated control under normoxia and hypoxia, respectively. (n=4; mean ± SEM, *p<0.05. Nox: normoxia, Hox: hypoxia). 
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